Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Kaj Blennow

Professor/ chief physician

Kaj Blennow
Professor/ chief physician
kaj.blennow@clinchem.gu.se

Postal Address: Su sahlgrenska, 41345 Göteborg
Visiting Address: Laborativ neurovetenskap , Göteborg


Department of Psychiatry and Neurochemistry at Institute of Neuroscience and Physiology (More Information)
Blå stråket 15, vån 3 SU/Sahlgrenska
413 45 Göteborg
031-342 10 00
Visiting Address: Blå stråket 15, vån 3 SU/Sahlgrenska , 413 45 Göteborg

About Kaj Blennow

Latest publications

Cerebrospinal fluid tau fragment correlates with tau PET: a candidate biomarker for tangle pathology.
Kaj Blennow, Chun Chen, Claudia Cicognola, Kristin R Wildsmith, Paul T Manser et al.
Brain : a journal of neurology, Journal article 2020
Journal article

Cerebrospinal fluid levels of neurogranin in Parkinsonian disorders.
Sara Hall, Shorena Janelidze, Henrik Zetterberg, Britta Brix, Niklas Mattsson et al.
Movement disorders : official journal of the Movement Disorder Society, Journal article 2020
Journal article

Special Issue CCA for the proceedings of the 2nd symposium of the Society of CSF analysis and clinical neurochemistry.
Charlotte Teunissen, Lucilla Parnetti, Kaj Blennow, Markus Otto
Clinica chimica acta; international journal of clinical chemistry, Journal article 2020
Journal article

Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration
E. H. Thijssen, R. La Joie, A. Wolf, A. Strom, P. Wang et al.
Nature Medicine, Journal article 2020
Journal article

Brain and blood biomarkers of tauopathy and neuronal injury in humans and rats with neurobehavioral syndromes following blast exposure
D. L. Dickstein, R. De Gasperi, M. G. A. Sosa, G. Perez-Garcia, J. A. Short et al.
Molecular Psychiatry, Journal article 2020
Journal article

Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings
L. Vermunt, G. Muniz-Terrera, L. ter Meulen, C. Veal, Kaj Blennow et al.
Alzheimer's Research & Therapy, Journal article 2020
Journal article

Showing 941 - 950 of 1153

2009

Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity is increased in Alzheimer disease.
Sonia Chalbot, Henrik Zetterberg, Kaj Blennow, Tormod Fladby, Inge Grundke-Iqbal et al.
Clinical chemistry, Journal article 2009
Journal article

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.
Leslie M Shaw, Hugo Vanderstichele, Malgorzata Knapik-Czajka, Christopher M Clark, Paul S Aisen et al.
Annals of neurology, Journal article 2009
Journal article

A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease.
N A Verwey, W M van der Flier, Kaj Blennow, C Clark, S Sokolow et al.
Annals of clinical biochemistry, Journal article 2009
Journal article

Zinc and copper modulate Alzheimer Abeta levels in human cerebrospinal fluid.
Dorothea Strozyk, Lenore J Launer, Paul A Adlard, Robert A Cherny, Andrew Tsatsanis et al.
Neurobiology of aging, Journal article 2009
Journal article

The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease.
Lidia Glodzik-Sobanska, Elizabeth Pirraglia, Miroslaw Brys, Susan De Santi, Lisa Mosconi et al.
Neurobiology of aging, Journal article 2009
Journal article

Sustained release of neuron-specific enolase to serum in amateur boxers.
Henrik Zetterberg, Fatih Tanriverdi, Kursad Unluhizarci, Ahmet Selcuklu, Fahrettin Kelestimur et al.
Brain injury : [BI], Journal article 2009
Journal article

Showing 941 - 950 of 1153

Page Manager: Webbredaktör|Last update: 9/1/2015
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?